Earnings Call · Q2 FY2024·2024-08-14

Q2 24EPS -33.33%·Rev n/aQ1 24EPS +9.09%·Rev n/aQ4 23EPS +9.09%·Rev n/aQ3 23EPS +7.11%·Rev n/a⚠ consensus missing

BRAINSTORM CELL THERAPEUTICS INC. BCLI

−3.1%1d on move date−3.4% vs SPY3d+6.3%5d+12.5%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCLI calls or request research access.

More BCLI calls Browse calls Request research access